Description
Release Date: 9/01/2011
Termination Date: 9/01/2013
Title: Medication Safety
Program:
Please view the video presentation by following the link below. Windows Media is required for viewing. If you have any questions regarding this presentation you may use the"Contact Us" Tab to submit an email. To earn CME credit foryour participation in this activity, you may access the post test following the completion of viewing the video.
Planning Committee and Planning Committee Disclosures:
The following planning committee members have no relevant financial relationships with commercial interests to disclose. Their educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity and they will not be personally compensated for their roles in the planning or execution of this proposed CME activity by an organization other than The Ohio State University.
SusanMoffatt-Bruce, MD, PhD
ReneeMallett, JD, MSN, MBA, RN
RobertWeber, PharmD, MS
MicheleMichaels, PharmD, BCPS
LisaSavage, PharmD, BCOP
Jodi Sheets
Robert J. Weber, PharmD, MS discloses he has the following relevant financial relationships with commercial interests to disclose. Advisory Board Membership: McKesson Executive Alliance; Stockholder: Columbia Laboratories;Editorial Board Involvement: Hospital Pharmacy, Critical Care Medicine. His educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity and he will no tbe personally compensated for his role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University.
Speaker and Speaker Disclosures:
Susan Moffatt-Bruce, MD, PhD, discloses she has no relevant financial relationships with commercial interests to disclose. Her presentation will not include discussion on unapproved or “off-label” usage of commercial products and/or devices.
Robert J. Weber, PharmD, MS, discloses he has the following relevant financial relationships with commercial interests to disclose. Advisory Board Membership: McKesson Executive Alliance; Stockholder:Columbia Laboratories; Editorial Board Involvement: Hospital Pharmacy Critical Care Medicine. His presentation will not include discussion on unapproved or“off-label” usage of commercial products and/or devices.
Note: The Quality & Patient Safety Presentation videos can be viewed on the Quality & Patient Safety page on OneSource at the link below. You’ll need to return here to the CCME website to take the post-test and receive CME credit.
Dates and Times
End Date: 9/1/2013
Objectives
Upon successful completion of this educational activity, the participant will be able to: 1. Identify characteristics of OSUMC’s medication safety program 2. Discuss medication safety technologies 3. Demonstrate the new medication administration in IHIS (Barcoding) 4. Review key points of medication reconciliation 5. Demonstrate other medication safety resources for OSUMC caregivers 6. Discuss the importance of staff involvement by highlighting recent “Good Catches”Internet Enduring Material Files
| File | Link |
|---|---|
|
Evaluation Form |
Download |
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.